The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...

There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...

The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

One study found that nearly a third of participants who received a harmless placebo during Covid ... vaccine is already outdated,” said Dr. Daniel Salmon, director of the Institute for Vaccine ...

During an interview in late April with Dr. Phil, Robert F. Kennedy Jr. reiterated his appeal to parents on vaccine safety: ...

COVID, sparking debate about 'immunity debt.' Experts suggest that COVID-19 safety measures, while effective against the ...